| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 157, Issue 7 2844-2850, Copyright © 1996 by American Association of Immunologists
ARTICLES |
E Gulbins, B Brenner, K Schlottmann, U Koppenhoefer, O Linderkamp, KM Coggeshall and F Lang
I. Institute of Physiology, University of Tuebingen, Germany.
The CD40 receptor is an important molecule regulating B lymphocyte proliferation, maturation, Ab class switching, and cell survival. In the present study, we identified signal transduction events triggered by cross-linking the CD40 receptor. Stimulation of Daudi B cells with anti-CD40 resulted in activation of p21ras, an important switch point in the regulation of cell growth and differentiation. Ras activation correlated with a stimulation of Rac1 and MEK-1 as well as tyrosine phosphorylation of phosphatidylinositol 3-kinase. Inhibition of endogenous Ras by transfection of transdominant inhibitory Ras prevented tyrosine phosphorylation or stimulation of phosphatidylinositol 3-kinase, Rac1, or MEK-1 upon CD40 receptor triggering, proving an activation of the Ras pathway by CD40. Ras activation was partially inhibited by either herbimycin A or calphostin pretreatment and completely inhibited by preincubation with a combination of both inhibitors, indicating a synergistic role for protein tyrosine kinases and diglycerides in Ras activation after CD40 stimulation. In support of a role for diglycerides, we detected a 30 +/- 5% decrease of cellular phosphatidylcholine content, correlating with a threefold increase of diacylglycerol synthesis induced by CD40. Supporting a role for protein tyrosine kinase, we measured a five- to eightfold stimulation of p56lyn and p58blk kinase activity. These results suggest the activation of the Ras pathway via an additive function of src kinases and phospholipases that may be important in the mediation of biologic effects after CD40 receptor engagement.
This article has been cited by other articles:
|
|
 |
|
  J. A. Flaxenburg, M. Melter, P. H. Lapchak, D. M. Briscoe, and S. Pal The CD40-Induced Signaling Pathway in Endothelial Cells Resulting in the Overexpression of Vascular Endothelial Growth Factor Involves Ras and Phosphatidylinositol 3-Kinase J. Immunol., June 15, 2004; 172(12): 7503 - 7509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Davies, J. Mason, M. J. O. Wakelam, L. S. Young, and A. G. Eliopoulos Inhibition of Phosphatidylinositol 3-Kinase- and ERK MAPK-regulated Protein Synthesis Reveals the Pro-apoptotic Properties of CD40 Ligation in Carcinoma Cells J. Biol. Chem., January 9, 2004; 279(2): 1010 - 1019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Thirukkumaran, J. M. Luider, D. A. Stewart, T. Cheng, S. M. Lupichuk, M. J. Nodwell, J. A. Russell, I. A. Auer, and D. G. Morris Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation Blood, July 1, 2003; 102(1): 377 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Awasthi, R. Mathur, A. Khan, B. N. Joshi, N. Jain, S. Sawant, R. Boppana, D. Mitra, and B. Saha CD40 Signaling Is Impaired in L. major-infected Macrophages and Is Rescued by a p38MAPK Activator Establishing a Host-protective Memory T Cell Response J. Exp. Med., April 21, 2003; 197(8): 1037 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Alain, K. Hirasawa, K. J. Pon, S. G. Nishikawa, S. J. Urbanski, Y. Auer, J. Luider, A. Martin, R. N. Johnston, A. Janowska-Wieczorek, et al. Reovirus therapy of lymphoid malignancies Blood, December 1, 2002; 100(12): 4146 - 4153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Grassme, V. Jendrossek, J. Bock, A. Riehle, and E. Gulbins Ceramide-Rich Membrane Rafts Mediate CD40 Clustering J. Immunol., January 1, 2002; 168(1): 298 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Segui, N. Andrieu-Abadie, S. Adam-Klages, O. Meilhac, D. Kreder, V. Garcia, A. P. Bruno, J.-P. Jaffrezou, R. Salvayre, M. Kronke, et al. CD40 Signals Apoptosis through FAN-regulated Activation of the Sphingomyelin-Ceramide Pathway J. Biol. Chem., December 24, 1999; 274(52): 37251 - 37258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Posner, L. A. Cavacini, M. P. Upton, K. C. Tillman, E. R. Gornstein, and C. M. Norris Jr. Surface Membrane-expressed CD40 Is Present on Tumor Cells from Squamous Cell Cancer of the Head and Neck in Vitro and in Vivo and Regulates Cell Growth in Tumor Cell Lines Clin. Cancer Res., August 1, 1999; 5(8): 2261 - 2270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-M. Park, H.-S. Kim, J. Choe, and T. H. Lee Differential Induction of Cytokine Genes and Activation of Mitogen-Activated Protein Kinase Family by Soluble CD40 Ligand and TNF in a Human Follicular Dendritic Cell Line J. Immunol., July 15, 1999; 163(2): 631 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Tognon, H. E. Kirk, L. A. Passmore, I. P. Whitehead, C. J. Der, and R. J. Kay Regulation of RasGRP via a Phorbol Ester-Responsive C1 Domain Mol. Cell. Biol., December 1, 1998; 18(12): 6995 - 7008. [Abstract] [Full Text]
|
|
|
|
|
|
A. Craxton, G. Shu, J. D. Graves, J. Saklatvala, E. G. Krebs, and E. A. Clark p38 MAPK Is Required for CD40-Induced Gene Expression and Proliferation in B Lymphocytes J. Immunol., October 1, 1998; 161(7): 3225 - 3236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Lazaar, Y. Amrani, J. Hsu, R. A. Panettieri Jr., W. C. Fanslow, S. M. Albelda, and E. Pure CD40-Mediated Signal Transduction in Human Airway Smooth Muscle J. Immunol., September 15, 1998; 161(6): 3120 - 3127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Grammer, J. L. Swantek, R. D. McFarland, Y. Miura, T. Geppert, and P. E. Lipsky TNF Receptor-Associated Factor-3 Signaling Mediates Activation of p38 and Jun N-Terminal Kinase, Cytokine Secretion, and Ig Production Following Ligation of CD40 on Human B Cells J. Immunol., August 1, 1998; 161(3): 1183 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-U. Simon, S. Yousefi, B. Dibbert, H. Hebestreit, M. Weber, D. R. Branch, K. Blaser, F. Levi-Schaffer, and G. P. Anderson Role for Tyrosine Phosphorylation and Lyn Tyrosine Kinase in Fas Receptor-Mediated Apoptosis in Eosinophils Blood, July 15, 1998; 92(2): 547 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Purkerson and D. C. Parker Differential Coupling of Membrane Ig and CD40 to the Extracellularly Regulated Kinase Signaling Pathway J. Immunol., March 1, 1998; 160(5): 2121 - 2129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kashiwada, Y. Shirakata, J.-I. Inoue, H. Nakano, K. Okazaki, K. Okumura, T. Yamamoto, H. Nagaoka, and T. Takemori Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) Stimulates Extracellular Signal-regulated Kinase (ERK) Activity in CD40 Signaling Along a Ras-independent Pathway J. Exp. Med., January 19, 1998; 187(2): 237 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Brenner, U. Koppenhoefer, C. Weinstock, O. Linderkamp, F. Lang, and E. Gulbins Fas- or Ceramide-induced Apoptosis Is Mediated by a Rac1-regulated Activation of Jun N-terminal Kinase/p38 Kinases and GADD153 J. Biol. Chem., August 29, 1997; 272(35): 22173 - 22181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tan, T. Town, and M. Mullan CD45 Inhibits CD40L-induced Microglial Activation via Negative Regulation of the Src/p44/42 MAPK Pathway J. Biol. Chem., November 17, 2000; 275(47): 37224 - 37231. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
